当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析

益佰制药

(600594)

  

流通市值:34.45亿  总市值:34.45亿
流通股本:7.92亿   总股本:7.92亿

益佰制药(600594)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-0.22亿元,每股收益-0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益258376.59万元,未分配利润73408.10万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产405232.15万元,负债146855.57万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入993,123,553.98501,480,776.322,174,031,578.871,713,840,317.37
营业总成本1,008,735,825.93512,206,331.732,434,804,131.131,842,847,294.11
其他经营收益
营业利润-20,844,463.65-10,478,077.98-312,253,471.83-163,471,482.03
利润总额-23,846,317.27-9,999,543.04-332,520,712.29-173,766,399.26
净利润-22,357,904.18-11,427,837.53-334,673,987.38-174,241,819.86
每股收益
其他综合收益13,486.5--198,981.0627,008.83
综合收益总额-22,344,417.68-11,427,837.53-334,872,968.44-174,214,811.03
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,778,568,674.381,685,288,665.381,750,026,094.891,732,617,097.29
非流动资产:
非流动资产合计2,273,752,864.12,309,614,143.352,349,675,146.592,434,540,393.75
资产总计4,052,321,538.483,994,902,808.734,099,701,241.484,167,157,491.04
流动负债:
流动负债合计990,815,878.8914,345,074.87949,012,491.4867,216,658.47
非流动负债:
非流动负债合计477,739,775.91485,875,269.94544,578,448.63523,165,200.58
负债合计1,468,555,654.711,400,220,344.811,493,590,940.031,390,381,859.05
所有者权益(或股东权益):
归属于母公司股东权益合计2,469,869,885.42,480,372,737.032,489,758,456.492,648,055,698.32
股东权益合计2,583,765,883.772,594,682,463.922,606,110,301.452,776,775,631.99
负债和股东权益合计4,052,321,538.483,994,902,808.734,099,701,241.484,167,157,491.04
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,217,131,510.06531,101,158.222,556,944,851.72,067,422,269.77
经营活动现金流出小计1,046,578,684.38523,574,806.092,470,071,814.821,867,618,947.16
经营活动产生的现金流量净额170,552,825.687,526,352.1386,873,036.88199,803,322.61
投资活动产生的现金流量:
投资活动现金流入小计22,486.822,486.812,486,881.4112,293,621.41
投资活动现金流出小计13,770,190.216,671,319.56116,323,71068,679,525.89
投资活动产生的现金流量净额-13,747,703.41-6,648,832.76-103,836,828.59-56,385,904.48
筹资活动产生的现金流量:
筹资活动现金流入小计402,999,999.5222,999,999.5560,000,000380,000,000
筹资活动现金流出小计385,660,119.87287,809,022.8719,706,367.19611,209,313.27
筹资活动产生的现金流量净额17,339,879.63-64,809,023.3-159,706,367.19-231,209,313.27
汇率变动对现金及现金等价物的影响-5,555.11-1,248.57-3,249.09-12,532
现金及现金等价物净增加额174,139,446.79-63,932,752.5-176,673,407.99-87,804,427.14
期末现金及现金等价物余额693,146,756.66455,074,557.37519,007,309.87607,876,290.72
补充资料:
现金及现金等价物的净增加额174,139,446.79--176,673,407.99-
TOP↑